WAG
IDXX icon

Wallace Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Wallace Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-465
Closed -$261K – 138
2026
Q1 		$261K Sell
465
-176
-27% -$113K 0.28% 100
2025
Q4 		$434K Sell
641
-558
-47% -$380K 0.46% 54
2025
Q3 		$643K Buy
+1,199
New +$728K 0.52% 48
2025
Q1 		– Sell
-474
Closed -$239K – 194
2024
Q4 		$239K Sell
474
-5
-1% -$2.19K 0.17% 156
2024
Q3 		$233K Hold
479
– – 0.17% 156
2024
Q2 		$233K Buy
+479
New +$240K 0.17% 156

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Wallace Advisory Group's IDXX Position: Q2 2026 in Review

Wallace Advisory Group sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 465 shares — an estimated $261K sold.

Wallace Advisory Group first reported a position in IDXX in Q2 2024 and held it in 6 quarters. The position peaked at $643K in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wallace Advisory Group reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Wallace Advisory Group sold 465 Idexx Laboratories shares in Q2 2026, an estimated $261K.
  • Wallace Advisory Group first reported a position in Idexx Laboratories in Q2 2024 and held it in 6 quarters.
  • Wallace Advisory Group's Idexx Laboratories position peaked at $643K in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wallace Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.